» Articles » PMID: 29650435

Relationship Between Oxidative Stress and Muscle Mass Loss in Early Postmenopause: an Exploratory Study

Overview
Date 2018 Apr 14
PMID 29650435
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Endocrine changes due to menopause have been associated to oxidative stress and muscle mass loss. The study objective was to determine the relationship between both variables in early postmenopause.

Material And Methods: An exploratory, cross-sectional study was conducted in 107 pre- and postmenopausal women (aged 40-57 years). Levels of serum lipid peroxides and uric acid and enzymes superoxide dismutase and glutathione peroxidase, as well as total plasma antioxidant capacity were measured as oxidative stress markers. Muscle mass using bioelectrical impedance and muscle strength using dynamometry were also measured. Muscle mass, skeletal muscle index, fat-free mass, and body mass index were calculated.

Results: More than 90% of participants were diagnosed with overweight or obesity. Postmenopausal women had lower values of muscle mass and strength markers, with a negative correlation between lipid peroxide level and skeletal muscle index (r= -0.326, p<.05), and a positive correlation between uric acid and skeletal muscle index (r=0.295, p<.05). A multivariate model including oxidative stress markers, age, and waist circumference showed lipid peroxide level to be the main contributor to explain the decrease in skeletal muscle mass in postmenopause, since for every 0.1μmol/l increase in lipid peroxide level, skeletal muscle index decreases by 3.03 units.

Conclusion: Our findings suggest an association between increased oxidative stress and muscle mass loss in early postmenopause.

Citing Articles

Analysis of Risk Factors for the Association of Sarcopenia in Patients with Type 2 Diabetes Mellitus.

Du Y, Wang Y, Zhang P, Zhong X, Pan T Diabetes Metab Syndr Obes. 2024; 17:1455-1466.

PMID: 38562278 PMC: 10982580. DOI: 10.2147/DMSO.S446894.


A comprehensive review on the risks assessment and treatment options for Sarcopenia in people with diabetes.

Johri N, Vengat M, Kumar D, Nagar P, John D, Dutta S J Diabetes Metab Disord. 2023; 22(2):995-1010.

PMID: 37975099 PMC: 10638272. DOI: 10.1007/s40200-023-01262-w.


Phase angle is related to oxidative stress and antioxidant biomarkers in breast cancer patients undergoing chemotherapy.

da Silva B, Rufato S, Mialich M, Cruz L, Gozzo T, Jordao A PLoS One. 2023; 18(6):e0283235.

PMID: 37289671 PMC: 10249836. DOI: 10.1371/journal.pone.0283235.


Phase angle and cellular health: inflammation and oxidative damage.

da Silva B, Orsso C, Gonzalez M, Sicchieri J, Mialich M, Jordao A Rev Endocr Metab Disord. 2022; 24(3):543-562.

PMID: 36474107 PMC: 9735064. DOI: 10.1007/s11154-022-09775-0.


Sarcopenia and Chronic Complications of Type 2 Diabetes Mellitus.

Purnamasari D, Tetrasiwi E, Kartiko G, Astrella C, Husam K, Laksmi P Rev Diabet Stud. 2022; 18(3):157-165.

PMID: 36309772 PMC: 9652710. DOI: 10.1900/RDS.2022.18.157.